Yield10 Bioscience is expanding its non-exclusive research license with Bayer for soybean crop research. The expanded agreement will include a new discovery related to its C3004 yield trait gene.

Seed yield

Yield10 is using novel trait genes C3003 and C3004 to increase seed yield in commercially important crops including soybean which is the second highest valued crop in the US. Bayer will have access to these new developments from Yield10’s C3004 program and new advanced technology related to the C3004 trait and its potential to increase seed yield.

Amended license

Under the amended research license, Bayer will have access to these new developments from Yield10’s C3004 program and new advanced technology related to the C3004 trait and its potential to increase seed yield.

Yield10 has previously shown that targeting C3003, a gene trait derived from algae, can produce increases in seed yield in oilseed crops, including canola. C3004, a Camelina plant gene, may increase activity in the C3003 plants.

In 2018, Yield10 reported that Camelina plants engineered only with increased activity of a novel C3004 gene produced significant increases in seed yield as well as increased vigor and branching in many of the plant lines tested in growth chamber studies. The exact role of C3004 is still being evaluated by Yield10.

“The early development work reported by Yield10 last year utilizing advanced technology for C3004 is promising, so we look forward to seeing if the results translate well in soybean crops,” said Scott Knight, Ph.D., Director of Genome Editing and Yield, Disease and Quality Research at Crop Science, a division of Bayer. “We continue to be impressed by Yield10’s capabilities and approach to identifying novel yield traits for oilseed crops. Bayer is committed to developing tailored solutions that meet the needs of farmers, while reducing modern agriculture’s environmental impact.”

Source: Yield10 and Bayer

The source is solely responsible for the information provided and is wholly owned by the source. Informa Business Media and all its subsidiaries are not responsible for any of the content contained in this information asset.